Total Funding
43
33
Total FundingPost-IPO Equity raised
Growth Score
1 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
159234
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
- Tony Gibney: Independent DirectorPast Role: IVERIC bio, Chief Business & Strategy Officer
Henry F. Edelhauser: Vice President, Scientific AffairsPast Role: Arvo Consultores, President
About the Company
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork,
and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
